L364-0109 Screening compound: N-methyl-4-[1-methyl-5-(1,3,5-trimethyl-1H-pyrazole-4-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

L364-0109 Screening compound: N-methyl-4-[1-methyl-5-(1,3,5-trimethyl-1H-pyrazole-4-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide
L364-0109 Screening compound: N-methyl-4-[1-methyl-5-(1,3,5-trimethyl-1H-pyrazole-4-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L364-0109
N-methyl-4-[1-methyl-5-(1,3,5-trimethyl-1H-pyrazole-4-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L364-0109

Molecular Formula

C22H24N6O3S (C22 H24 N6 O3 S)

Compound Name

N-methyl-4-[1-methyl-5-(1,3,5-trimethyl-1H-pyrazole-4-sulfonamido)-1H-1,3-benzodiazol-2-yl]benzamide

IUPAC name

N-methyl-4-[1-methyl-5-(135-trimethyl-1H-pyrazole-4-sulfonamido)-1H-13-benzodiazol-2-yl]benzamide

SMILES

Cc(n(C)nc1C)c1S(Nc(cc1)cc2c1n(C)c(-c(cc1)ccc1C(NC)=O)n2)(=O)=O

InChI

InChI=1S/C22H24N6O3S/c1-13-20(14(2)28(5)25-13)32(30,31)26-17-10-11-19-18(12-17)24-21(27(19)4)15-6-8-16(9-7-15)22(29)23-3/h6-12,26H,1-5H3,(H,23,29)

InChI Key

FHTLSFPYATVXHV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247844

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452.54

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.793

Distribution Coefficient, logD

1.778

Water Solubility, LogSw

-2.60

Polar Surface Area

91.301

Acid Dissociation Constant (pKa)

8.99

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

L364-0109 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L364-0109 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L364-0109?
Check Price and Availability of L364-0109, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L364-0109 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L364-0109
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L364-0109
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L364-0109 available by request